MANAGEMENT OF ENDOCRINE DISEASE: Non-alcoholic fatty liver disease: a multidisciplinary approach towards a cardiometabolic liver disease in: European Journal of Endocrinology Volume 183 Issue 3 (2020)
Nonalcoholic Fatty Liver Disease: A Pathological View | IntechOpen
Fatty Liver Disease: Alcoholic and Nonalcoholic | Abdominal Key
Human translatability of the GAN diet-induced obese mouse model of non-alcoholic steatohepatitis | BMC Gastroenterology | Full Text
Tesamorelin for the Potential Treatment of NASH | Theratechnologies Inc.
GI/Liver Path on Twitter: ""Feathery" vs "Ballooning" degeneration: Similarities: Overlapping features of swollen, enlarged & injured hepatocytes with cytoplasmic reticulation. Differences: Ballooning-Steatohepatitis, mallory-denk, glycogenated ...
imageDx: NASH - A New Generation of Quantitative NASH Data
Effect of Metformin on Ballooning Degeneration in Nonalcoholic Steatohepatitis (NASH): When to Use Metformin in Nonalcoholic Fatty Liver Disease (NAFLD) | SpringerLink
Applied Sciences | Free Full-Text | Training of Deep Convolutional Neural Networks to Identify Critical Liver Alterations in Histopathology Image Samples
NASH / Fibrosis - By universe - Life sciences
Macro steatosis, micro steatosis and ballooning in liver of insulin resistant baboons.
Webpathology.com: A Collection of Surgical Pathology Images
Non-alcoholic Fatty Liver Disease (NAFLD) and Nonalcoholic Steatohepatitis (NASH)_Liver Disease Models_Kunming Biomed International (KBI)